Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

ASLN

ASLAN Pharmaceuticals (ASLN)

ASLAN Pharmaceuticals Ltd
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ASLN
DatumZeitQuelleÜberschriftSymbolFirma
19/11/202013h21GlobeNewswire Inc.ASLAN Pharmaceuticals to Present at Upcoming Piper Sandler Investor ConferenceNASDAQ:ASLNASLAN Pharmaceuticals Ltd
13/11/202012h06Edgar (US Regulatory)Amended Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k/a)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
09/11/202015h00Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
09/11/202013h00GlobeNewswire Inc.ASLAN Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Corporate UpdateNASDAQ:ASLNASLAN Pharmaceuticals Ltd
22/10/202013h30GlobeNewswire Inc.ASLAN Pharmaceuticals Initiates Third Dose Cohort of ASLAN004 in Atopic Dermatitis Clinical TrialNASDAQ:ASLNASLAN Pharmaceuticals Ltd
16/10/202011h25GlobeNewswire Inc.ASLAN Pharmaceuticals to Develop ASLAN003 as Next Generation DHODH Inhibitor in Autoimmune ConditionsNASDAQ:ASLNASLAN Pharmaceuticals Ltd
09/10/202023h04Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
09/10/202022h05Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
22/09/202012h02Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
21/09/202012h00GlobeNewswire Inc.ASLAN Pharmaceuticals Completes Enrolment in Second Cohort and Opens New Sites in US and Australia in ASLAN004 Atopic Dermati...NASDAQ:ASLNASLAN Pharmaceuticals Ltd
10/09/202009h08GlobeNewswire Inc.ASLAN Pharmaceuticals to Present at H.C. Wainwright 22nd Annual Global Investment ConferenceNASDAQ:ASLNASLAN Pharmaceuticals Ltd
04/09/202023h01Edgar (US Regulatory)Securities Registration (ads, Immediate) (f-6ef)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
04/09/202016h15Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
24/08/202015h25Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
24/08/202009h27GlobeNewswire Inc.ASLAN Pharmaceuticals Resumes Recruitment of New Patients Into ASLAN004 StudyNASDAQ:ASLNASLAN Pharmaceuticals Ltd
07/08/202009h00GlobeNewswire Inc.ASLAN Pharmaceuticals to Participate in Fireside Chat at BTIG Virtual Biotechnology Conference 2020NASDAQ:ASLNASLAN Pharmaceuticals Ltd
03/08/202012h25Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
03/08/202009h17GlobeNewswire Inc.ASLAN Pharmaceuticals Appoints Kenneth Kobayashi, MD, as Chief Medical OfficerNASDAQ:ASLNASLAN Pharmaceuticals Ltd
17/07/202012h08GlobeNewswire Inc.ASLAN Pharmaceuticals Announces the Move of its Primary Listing to Nasdaq and Delisting From Taipei ExchangeNASDAQ:ASLNASLAN Pharmaceuticals Ltd
17/07/202012h05Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
13/07/202018h31Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
13/07/202014h06GlobeNewswire Inc.ASLAN Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Corporate UpdateNASDAQ:ASLNASLAN Pharmaceuticals Ltd
15/06/202012h23Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
09/06/202022h32Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
12/05/202012h06Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
11/05/202011h34GlobeNewswire Inc.ASLAN Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Corporate UpdateNASDAQ:ASLNASLAN Pharmaceuticals Ltd
05/05/202012h06Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
16/04/202015h00Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
13/04/202016h15Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
13/04/202011h17GlobeNewswire Inc.UPDATE - ASLAN Pharmaceuticals Temporarily Pauses Recruitment of New Patients Into ASLAN004 Study Due to COVID-19NASDAQ:ASLNASLAN Pharmaceuticals Ltd
 Showing the most relevant articles for your search:NASDAQ:ASLN

Kürzlich von Ihnen besucht